# Shandong Xinhua Pharmaceutical Company Limited – FDA Inspection, Mar 29, 2019

Source: https://www.keypedia.com/records/fda_inspections/shandong-xinhua-pharmaceutical-company-limited/92338ae1-9f91-46e4-bd2c-776ae27f2a10
Source feed: FDA_Inspections

> FDA inspection 1087221 of Shandong Xinhua Pharmaceutical Company Limited, March 29, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1087221
- Company Name: Shandong Xinhua Pharmaceutical Company Limited
- Inspection Date: 2019-03-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1237492 - 2024-04-05
- FDA Inspection 997761 - 2016-03-31
- FDA Inspection 876774 - 2014-04-04

## Related Officers

- [Arsen Karapetyan](https://www.keypedia.com/people/arsen-karapetyan/4000d909-277b-4533-992f-4e3627c8ce40)

Company: https://www.keypedia.com/companies/shandong-xinhua-pharmaceutical-company-limited/7350901d-493e-45cb-a67f-c73093cf762e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
